Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.44 |
| ▸ | FABP4 | P15090 | 1/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MYC | P01106 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HNF4A | P41235 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9391411 | 0.87 | KMT2A (0.48) | FABP3FABP4FABP5ALDH1A1GAA | |
| SCHEMBL10679197 | 0.78 | CSNK2A1 (0.45) | ALDH1A1KDM4ECA12CA1CA2 | |
| SCHEMBL10681393 | 0.77 | KDM4E (0.44) | FABP3FABP4ALDH1A1KDM4EHPGD | |
| SCHEMBL2534345 | 0.77 | AKR1B1 (0.46) | ALDH1A1CYP2C9KDM4EMAPT | |
| SCHEMBL30028907 | 0.72 | ALDH1A1 (0.72) | ALDH1A1ALOX15GAAMYCCYP3A4 | |
| SCHEMBL36145 | 0.72 | ALDH1A1 (0.72) | ALDH1A1ALOX15GAAMYCCYP3A4 | |
| SCHEMBL25394857 | 0.71 | NPC1 (0.47) | ALDH1A1GAAKDM4ERAB9ATSHR | |
| SCHEMBL25395879 | 0.71 | NPC1 (0.47) | ALDH1A1GAAKDM4ERAB9ATSHR | |
| SCHEMBL483513 | 0.71 | NPC1 (0.47) | ALDH1A1GAAKDM4ERAB9ATSHR | |
| SCHEMBL9404581 | 0.71 | HPGD (0.47) | ALDH1A1ALOX15GAACYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8975038-B2 | Method for determining presence of carcinomic cells with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine | BIOAFFINITY TECHNOLOGIES, INC. (US) | 2015-03-10 | — | — | US | claimed |
| EP-2372361-B1 | Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine | BIOMODA INC (US) | 2014-08-06 | — | — | EP | claimed |
| US-20140162287-A1 | Method for Prognosing Response to Cancer Therapy with 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine | BIOMODA, INC. | 2014-06-12 | — | — | US | claimed |
| EP-1364044-B1 | COMPOSITIONS AND METHODS FOR DETECTING PRE-CANCEROUS CONDITIONS IN CELL AND TISSUE SAMPLES USING 5, 10, 15, 20-TETRAKIS (CARBOXYPHENYL) PORPHINE | BIOMODA INC (US) | 2012-01-11 | — | — | EP | claimed |
| US-7960138-B2 | Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine | BIOMODA, INC. (US) | 2011-06-14 | — | — | US | claimed |
| US-7384764-B2 | Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine | BIOMODA, INC. (US) | 2008-06-10 | — | — | US | claimed |
| WO-2004041828-A1 | METHOD OF USING A PORPHYRIN-LIKE MOLECULE CONJUGATED WITH AN ANTI-CANCER DRUG FOR THE TREATMENT OF CANCER | HAN IN SUK (US) | 2004-05-21 | — | — | WO | claimed |
| US-20020155999-A1 | Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer | HAN IN SUK (US) | 2002-10-24 | — | — | US | claimed |
| US-8975038-B2 | Method for determining presence of carcinomic cells with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine | BIOAFFINITY TECHNOLOGIES, INC. (US) | 2015-03-10 | — | — | US | disclosed |
| US-20140162287-A1 | Method for Prognosing Response to Cancer Therapy with 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine | BIOMODA, INC. | 2014-06-12 | — | — | US | disclosed |
| EP-1364044-B1 | COMPOSITIONS AND METHODS FOR DETECTING PRE-CANCEROUS CONDITIONS IN CELL AND TISSUE SAMPLES USING 5, 10, 15, 20-TETRAKIS (CARBOXYPHENYL) PORPHINE | BIOMODA INC (US) | 2012-01-11 | — | — | EP | disclosed |
| EP-1364044-B1 | COMPOSITIONS AND METHODS FOR DETECTING PRE-CANCEROUS CONDITIONS IN CELL AND TISSUE SAMPLES USING 5, 10, 15, 20-TETRAKIS (CARBOXYPHENYL) PORPHINE | BIOMODA INC (US) | 2012-01-11 | — | — | EP | disclosed |
| EP-2372361-A1 | Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine | Biomoda, Inc. (US) | 2011-10-05 | — | — | EP | disclosed |
| EP-2372361-A1 | Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine | Biomoda, Inc. (US) | 2011-10-05 | — | — | EP | disclosed |
| US-7384764-B2 | Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine | BIOMODA, INC. (US) | 2008-06-10 | — | — | US | disclosed |
| US-20050233410-A1 | Detecting cancerous and precancerous cells; obtain tissue sample, incubate wih tetrakis dyes, rince and remove unbound dye, detect fluorescence, fuorescence indicates cancerous or precancerous cells | BIOMODA, INC. | 2005-10-20 | — | — | US | disclosed |
| US-20050233410-A1 | Detecting cancerous and precancerous cells; obtain tissue sample, incubate wih tetrakis dyes, rince and remove unbound dye, detect fluorescence, fuorescence indicates cancerous or precancerous cells | BIOMODA, INC. | 2005-10-20 | — | — | US | disclosed |
| CN-1545557-A | Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine | �ݰ�Ī�﹫˾ | 2004-11-10 | — | — | CN | disclosed |
| US-20020155999-A1 | Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer | HAN IN SUK (US) | 2002-10-24 | — | — | US | disclosed |
| US-5162231-A | Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung | LOS ALAMOS NATIONAL SECURITY, LLC | 1992-11-10 | — | — | US | disclosed |